查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614339

藥品契約製造市場：按產品、最終用戶分類 - 2025-2030 年全球預測

Fill-finish Pharmaceutical Contract Manufacturing Market by Product (Consumables, Instruments), End-users (Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥品契約製造市場規模為104.7億美元，預計2024年將達到113.8億美元，複合年成長率為9.28%，預計到2030年將達到194.9億美元。

藥品契約製造是指藥品製造過程最後階段的外包，即藥品被填充到管瓶和注射器等容器中並包裝以進行分銷。由於其資源密集和監管性質，這項服務至關重要，並且對於內部管理能力有限的小型企業或組織來說可能很困難。灌裝-加工服務的最終用途應用包括製藥公司、生技公司和醫療保健組織。市場的關鍵成長要素包括生技藥品和生物相似藥產量的增加、注射劑需求的成長、個人化醫療的進步以及推動先進藥物輸送系統的慢性病盛行率的上升。最近的技術進步，例如填充-加工作業的自動化和包裝材料的創新，為製造商提供了提高效率和降低污染風險的潛在機會。為了利用這一點，公司應該專注於擴展其複雜配方的能力並投資於永續的包裝解決方案。然而，高營運成本、嚴格的監管要求以及對專業設施的需求等挑戰可能會阻礙市場成長。此外，由於全球供應鏈面臨挑戰，COVID-19 大流行造成的干擾仍然令人擔憂。創新領域包括開發環保製造流程、將數位追蹤技術整合到灌裝和塗飾作業中，以及加強品質保證以提高準確性和安全性。市場動態是一個充滿活力的市場，其特點是競爭激烈、技術進步迅速，持續的研發投資和產能擴張對於持續成長至關重要。與生物技術創新者合作並實施適應性強的製造解決方案對於未來的市場領導地位至關重要。

主要市場統計
基準年[2023] 104.7億美元
預計年份 [2024] 113.8億美元
預測年份 [2030] 194.9億美元
複合年成長率（%） 9.28%

市場動態：揭示快速發展的藥品契約製造市場的關鍵市場洞察

藥品契約製造市場正在因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 生物製藥核准數量增加
    • 技術進步和填充加工製造流程外包的增加
    • 擴大多產品導向設施的使用
  • 市場限制因素
    • 服務成本上升及監管環境複雜
  • 市場機會
    • 更多採用自動化和機器人技術，以提高填充完成表面處理工程的效率、準確性和安全性
    • 擴大轉向支持個人化醫療的靈活製造系統
  • 市場挑戰
    • 與維持相關生產設施無菌相關的技術問題

波特五力：駕馭藥品契約製造市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥品契約製造市場的外部影響

外部宏觀環境因素在塑造藥品契約製造市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥品契約製造市場的競爭狀況

藥品契約製造市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 醫藥契約製造市場中的定位矩陣供應商績效評估

FPNV定位矩陣是評估藥品契約製造市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪藥品契約製造市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，藥品契約製造市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物製藥核准數量增加
      • 填充和表面處理製造流程和外包方面的技術不斷進步
      • 擴大多產品設施的使用
    • 抑制因素
      • 高成本和複雜的監管環境
    • 機會
      • 擴展自動化和機器人技術，以提高填充和表面處理工程的效率、準確性和安全性
      • 更多轉向個人化醫療的靈活製造系統
    • 任務
      • 與維持相關生產設施無菌相關的技術問題
  • 市場區隔分析
    • 產品：填充和精整操作儀器的進步
    • 最終用戶：製藥和生物製藥公司的各種應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品契約製造市場：依產品

  • 消耗品
    • 安瓿
    • 瓶子
    • 墨水匣
    • IVs
    • 預填充式注射器
    • 管瓶
  • 裝置
    • 機器類型
    • 系統
      • 綜合系統
      • 獨立系統

第7章 藥品契約製造市場：依最終用戶分類

  • 學術研究所
  • 契約製造組織
  • 製藥和生物製藥公司
  • 研發機構

第 8 章：美洲藥品契約製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太藥品契約製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲藥品契約製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 斯蒂瓦那托集團推出 EZ 填充套件以及實驗室填充和精加工服務
    • Cytovance Biologics 和 Alcami 合作最佳化無菌填充和精加工操作
    • 三星生物製品公司和 Kuruma Partners 宣佈建立策略合作夥伴關係，為 Kuruma 投資組合公司開發和製造生技藥品
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma Services
  • Argonaut Manufacturing Services
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Chemtech International, Inc.
  • Eurofins Scientific SE
  • Federal Equipment Company
  • Fresenius Kabi Contract Manufacturing
  • GBI Biomanufacturing
  • Gerresheimer AG
  • Grand River Aseptic Manufacturing
  • Groninger & Co. GmbH
  • Jubilant HollisterStier CMO
  • MabPlex International Co. Ltd.
  • Novartis AG
  • OPTIMA Packaging Group GmbH
  • Pfizer Inc.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Societal CDMO
  • Syngene International Ltd.
  • Syntegon Pharma Technology
  • Vetter Pharma International
Product Code: MRR-0D217D5B027E

The Fill-finish Pharmaceutical Contract Manufacturing Market was valued at USD 10.47 billion in 2023, expected to reach USD 11.38 billion in 2024, and is projected to grow at a CAGR of 9.28%, to USD 19.49 billion by 2030.

Fill-finish pharmaceutical contract manufacturing refers to the outsourcing of the final steps in the pharmaceutical production process, where drug products are filled into vials, syringes or other containers, and packaged for distribution. This service is critical due to its resource-intensive and regulatory-compliant nature, which smaller companies or organizations with limited capacity may struggle to manage in-house. The application scope of fill-finish services is broad, covering biologics, vaccines, and other injectables, with end-use domains spanning across pharmaceutical companies, biotechnology firms, and healthcare institutions. Key growth influences in this market include the increasing production of biologics and biosimilars, growing demand for injectables, advancement in personalized medicine, and the rising prevalence of chronic diseases that push for sophisticated drug delivery systems. Recent technological advancements, such as automation in fill-finish operations, and innovation in packaging materials, present potential opportunities for manufacturers to enhance efficiency and reduce contamination risks. To capitalize, companies should focus on expanding capabilities to accommodate complex formulations and invest in sustainable packaging solutions. However, challenges such as high operational costs, stringent regulatory requirements, and the need for specialized facilities could hamper market growth. Further, the COVID-19 pandemic-induced disruptions remain a concern due to the global supply chain challenges. Areas ripe for innovation include development of eco-friendly manufacturing processes, integration of digital tracking technologies during fill-finish operations, and enhancements in quality assurance to augment precision and safety. The fill-finish pharmaceutical contract manufacturing market is dynamic, characterized by intense competition and rapid technological advancement, making continual investment in R&D and capacity expansion vital for sustaining growth. Embracing collaborations with biotech innovators and implementing adaptable manufacturing solutions are crucial for future market leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 10.47 billion
Estimated Year [2024] USD 11.38 billion
Forecast Year [2030] USD 19.49 billion
CAGR (%) 9.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fill-finish Pharmaceutical Contract Manufacturing Market

The Fill-finish Pharmaceutical Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of biologic drugs approval
    • Increasing technological advancements in fill-finish manufacturing processes and outsourcing
    • Growing usage of multi-product-use-oriented facilities
  • Market Restraints
    • High cost of services and complex regulatory landscape
  • Market Opportunities
    • Increasing adoption of automation and robotics to enhance efficiency, accuracy, and safety in fill-finish processes
    • Rising shift towards flexible manufacturing systems catering to personalized medicine
  • Market Challenges
    • Technical issues related to maintaining sterility in associated manufacturing facility

Porter's Five Forces: A Strategic Tool for Navigating the Fill-finish Pharmaceutical Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fill-finish Pharmaceutical Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fill-finish Pharmaceutical Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fill-finish Pharmaceutical Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fill-finish Pharmaceutical Contract Manufacturing Market

A detailed market share analysis in the Fill-finish Pharmaceutical Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fill-finish Pharmaceutical Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fill-finish Pharmaceutical Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fill-finish Pharmaceutical Contract Manufacturing Market

A strategic analysis of the Fill-finish Pharmaceutical Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fill-finish Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Ajinomoto Bio-Pharma Services, Argonaut Manufacturing Services, Baxter International, Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Chemtech International, Inc., Eurofins Scientific SE, Federal Equipment Company, Fresenius Kabi Contract Manufacturing, GBI Biomanufacturing, Gerresheimer AG, Grand River Aseptic Manufacturing, Groninger & Co. GmbH, Jubilant HollisterStier CMO, MabPlex International Co. Ltd., Novartis AG, OPTIMA Packaging Group GmbH, Pfizer Inc., Piramal Pharma Solutions, Recipharm AB, Societal CDMO, Syngene International Ltd., Syntegon Pharma Technology, and Vetter Pharma International.

Market Segmentation & Coverage

This research report categorizes the Fill-finish Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Ampoules, Bottles, Cartridges, IVs, Prefilled Syringes, and Vials. The Instruments is further studied across Machine Type and Systems. The Systems is further studied across Integrated Systems and Standalone Systems.
  • Based on End-users, market is studied across Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, and Research & Development laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of biologic drugs approval
      • 5.1.1.2. Increasing technological advancements in fill-finish manufacturing processes and outsourcing
      • 5.1.1.3. Growing usage of multi-product-use-oriented facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of services and complex regulatory landscape
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of automation and robotics to enhance efficiency, accuracy, and safety in fill-finish processes
      • 5.1.3.2. Rising shift towards flexible manufacturing systems catering to personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Technical issues related to maintaining sterility in associated manufacturing facility
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Advancements in instrumentations for fill-finish operations
    • 5.2.2. End-users: Diverse applications in pharmaceutical & biopharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fill-finish Pharmaceutical Contract Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Ampoules
    • 6.2.2. Bottles
    • 6.2.3. Cartridges
    • 6.2.4. IVs
    • 6.2.5. Prefilled Syringes
    • 6.2.6. Vials
  • 6.3. Instruments
    • 6.3.1. Machine Type
    • 6.3.2. Systems
      • 6.3.2.1. Integrated Systems
      • 6.3.2.2. Standalone Systems

7. Fill-finish Pharmaceutical Contract Manufacturing Market, by End-users

  • 7.1. Introduction
  • 7.2. Academic Research Institutions
  • 7.3. Contract Manufacturing Organizations
  • 7.4. Pharmaceutical & Biopharmaceutical Companies
  • 7.5. Research & Development laboratories

8. Americas Fill-finish Pharmaceutical Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fill-finish Pharmaceutical Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fill-finish Pharmaceutical Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Stevanato Group Launches EZ-fill Kit and Laboratory Fill and Finish Service
    • 11.3.2. Cytovance Biologics, Alcami Partner to Optimize Sterile Fill-Finish Ops
    • 11.3.3. Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companies
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Ajinomoto Bio-Pharma Services
  • 3. Argonaut Manufacturing Services
  • 4. Baxter International, Inc.
  • 5. Boehringer Ingelheim International GmbH
  • 6. Catalent Inc.
  • 7. Chemtech International, Inc.
  • 8. Eurofins Scientific SE
  • 9. Federal Equipment Company
  • 10. Fresenius Kabi Contract Manufacturing
  • 11. GBI Biomanufacturing
  • 12. Gerresheimer AG
  • 13. Grand River Aseptic Manufacturing
  • 14. Groninger & Co. GmbH
  • 15. Jubilant HollisterStier CMO
  • 16. MabPlex International Co. Ltd.
  • 17. Novartis AG
  • 18. OPTIMA Packaging Group GmbH
  • 19. Pfizer Inc.
  • 20. Piramal Pharma Solutions
  • 21. Recipharm AB
  • 22. Societal CDMO
  • 23. Syngene International Ltd.
  • 24. Syntegon Pharma Technology
  • 25. Vetter Pharma International

LIST OF FIGURES

  • FIGURE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY IVS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY MACHINE TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH & DEVELOPMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 237. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023